Skip to main content

Advertisement

Table 3 Patients’ medication at the beginning of the study

From: Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain

Medication at beginning of the study CLBP (n = 19) NeP (n = 19)
Ibuprofen (no. (%)) 3 (16) 2 (11)
Diclofenac (no. (%)) 2 (11) 3 (16)
Paracetamol (no. (%)) 3 (16) 2 (11)
Metamizole (no. (%)) 1 (5) 1 (5)
Opioids (no. (%)) 2 (11) 3 (16)
Pregabalin (no. (%)) 0 (0) 1 (5)
Duloxetine (no. (%)) 0 (0) 1 (5)
  1. There is no significant difference in the intake of analgesics or coanalgesics in patients with CLBP and NeP. Data are presented as mean ± SD, n = 19, statistical testing was performed using Fisher’s exact test
  2. CLBP chronic low back pain; NeP neuropathic pain (symmetrical polyneuropathy, peripheral mononeuropathy, postherpetic neuralgia, orofacial pain)